The effect of gastrectomy on regorafenib exposure and progression‐free survival in patients with advanced gastrointestinal stromal tumours

AIMS: We investigated whether major gastrectomy influences the plasma exposure of regorafenib and treatment outcome. METHODS: Efficacy and pharmacokinetic data from 133 gastrointestinal stromal tumour patients included in a phase III trial were analysed. Patients were subdivided into 2 groups accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubberman, Floor J.E., van der Graaf, Winette T.A., Xu, Lei, Cleton, Adriaan, Demetri, George D., Gelderblom, Hans, van Erp, Nielka P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783594/
https://www.ncbi.nlm.nih.gov/pubmed/31290566
http://dx.doi.org/10.1111/bcp.14061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783594/
https://www.ncbi.nlm.nih.gov/pubmed/31290566
http://dx.doi.org/10.1111/bcp.14061

Ejemplares similares